US20200157472A1 - Detergent Composition - Google Patents

Detergent Composition Download PDF

Info

Publication number
US20200157472A1
US20200157472A1 US16/749,716 US202016749716A US2020157472A1 US 20200157472 A1 US20200157472 A1 US 20200157472A1 US 202016749716 A US202016749716 A US 202016749716A US 2020157472 A1 US2020157472 A1 US 2020157472A1
Authority
US
United States
Prior art keywords
protease
composition
phe
residue
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/749,716
Inventor
Lone Kierstein Nielsen
Lise Munch Mikkelsen
Esben Peter Friis
Juergen Carsten Franz Knoetzel
Ole Simonsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to US16/749,716 priority Critical patent/US20200157472A1/en
Publication of US20200157472A1 publication Critical patent/US20200157472A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/26—Organic compounds containing nitrogen
    • C11D3/33—Amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38663—Stabilised liquid enzyme compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
    • C11D7/22—Organic compounds
    • C11D7/32—Organic compounds containing nitrogen
    • C11D7/3245—Aminoacids

Definitions

  • the present invention relates to a liquid detergent composition comprising a surfactant and a protease and to a liquid enzyme composition comprising a protease and optionally a second enzyme. More particularly, it relates to such compositions incorporating a compound which stabilizes the protease and/or the second enzyme. Further, the invention also relates to a stabilizing compound for use in such compositions.
  • EP 0 583 534 A, WO 94/04651 A, WO 98/13458 A and WO 2007/145963 A describe enzyme stabilization in liquid detergent compositions comprising a reversible peptide aldehyde protease inhibitor.
  • WO 95/25791 A describes methods for manufacturing protease enzymes using non-protein protease inhibitors.
  • ⁇ -MAPI, antipain, GE20372A and chymostatin A, B and C are described as peptide aldehydes with activity as protease inhibitors: R. J. Broadbridge et al., Chem. Commun. (1998), 1449. E. Sarubbi et al., FEBS Letters, 319 (3), 253-256 (1993). I. J. Galpin et al., Int. J. Peptide Protein Res., 23, 1984, 477-486.
  • peptide aldehydes containing a “double N-capping group” such as ureido (N—CO—N), oxamide (N—CO—CO—N), thioureido (N—CS—N), dithio-oxamide (N—CS—CS—N) or thiooxamide (N—CS—CO—N) group
  • a “double N-capping group” such as ureido (N—CO—N), oxamide (N—CO—CO—N), thioureido (N—CS—N), dithio-oxamide (N—CS—CS—N) or thiooxamide (N—CS—CO—N) group
  • a detergent composition comprising a surfactant, a protease and a stabilizer of the formula:
  • one X is the “double N-capping group” CO, CO—CO, CS, CS—CS or CS—CO (most preferably CO), and the other X'es are nothing (i.e., a chemical bond),
  • n 1-10, preferably 2-5, most preferably 3
  • i is an integer from 1 to n
  • each A i and A n+1 is an amino acid residue having the structure:
  • R is H— or an optionally substituted alkyl or alkylaryl group which may optionally include a hetero atom and may optionally be linked to the N atom, and
  • P is hydrogen or any C-terminal protection group.
  • the invention also provides an enzyme composition, comprising a protease at a concentration of at least 0.1% by weight of enzyme protein and a stabilizer of the above formula.
  • the invention provides an enzyme composition, comprising a protease, a second enzyme and a stabilizer of the above formula.
  • the invention provides a stabilizer having the formula HO-A 1 -CO-A 2 -A 3 -A 4 -H, wherein A 1 is a Phe residue, A 2 is an Arg or Gly residue, A 3 is a Val or Gly residue, and A 4 is a Tyr residue.
  • the structure is P—O-A 1 -CO-A 2 -A 3 -A 4 -H, P—O-A 1 -A 2 -CO-A 3 -A 4 -H or P—O-A 1 -A 2 -A 3 -CO-A 4 -H, where the amino acid residue(s) to the right of the ureido group has/have the structure —NH—CR—CO—, and the residue(s) to the left of the ureido group is/are inverted to —CO—CR—NH—.
  • a i and A n+1 may be a residue of an amino acid, e.g. an L-amino acid, particularly a naturally occurring amino acid, L-norleucine (Nle), L-norvaline (Nva) or capreomycidine (Cpd).
  • a 1 may be Tyr, Leu, Phe, Met, Nle or Nva
  • a 2 may be Gly, Ala, Val, Arg, Leu or Cpd
  • a 3 may be Ala, Val, Gly, Leu, or Ile
  • a 4 may be Phe, Tyr, Leu, Nva, Nle, Met or Arg.
  • P may be H— or the C-terminal protection group Me-, Et- or CF 3 —
  • the stabilizer may have the formula HO-A 1 -CO-A 2 -A 3 -A 4 -H, e.g. the following compounds (where each amino acid is in the L-form unless indicated):
  • the stabilizer may be prepared by methods known in the art, e.g. as described by R. J. Broadbridge et al., Chem. Commun., 1998, 1449-1450; by P. Page et al., J. Org. Chem., 1999, 64, 794-799; or by I. J. Galpin et al., Int. J. Peptide Protein Res., 23, 1984, 477-486.
  • the molar ratio of the inhibitor to the protease may be 0.1:1 to 100:1, e.g. 0.5:1-50:1, 1:1-25:1 or 2:1-10:1.
  • the enzyme or detergent composition may comprise one or more other protease stabilizers.
  • examples are boronic acid derivatives, organic acids, protein and peptide type inhibitors and peptide aldehydes, e.g. as described in WO 1995/029223, WO 1996/041859, WO 2006/045310, WO 2006/045310, WO 2007/113142, WO 2008/116915, WO 2009/095425 (patent application EP 08150977.0), WO 2009/118375 (patent application EP 08153299.6), WO 2007/145963, or WO 2007/141736.
  • the protease may be a serine, cysteine or aspartic protease. It may be an alkaline microbial protease, a trypsin-like protease or a subtilisin, e.g. a subtilisin derived from Bacillus.
  • the protease may be subtilisin Novo, subtilisin Carlsberg, subtilisin BPN′, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279), trypsin (e.g.
  • proteases examples include KannaseTM, EverlaseTM, EsperaseTM, AlcalaseTM, NeutraseTM, DurazymTM, SavinaseTM, OvozymeTM, LiquanaseTM, PolarzymeTM, PyraseTM, Pancreatic Trypsin NOVO (PTN), Bio-FeedTM Pro and Clear-LensTMPro (all available from Novozymes A/S, Bagsvaerd, Denmark).
  • proteases include RonozymeTM Pro, MaxataseTM, MaxacalTM, MaxapemTM, OpticleanTM, ProperaseTM, PurafectTM, Purafect OxTM and Purafact PrimeTM (available from Danisco Genencor, Gist-Brocades, BASF, or DSM Nutritional Products).
  • the liquid composition may optionally comprise one or more other enzymes, e.g. selected among amylases, lipolytic enzymes (particularly lipases), cellulases, mannanases and oxidoreductases.
  • other enzymes e.g. selected among amylases, lipolytic enzymes (particularly lipases), cellulases, mannanases and oxidoreductases.
  • the amylase may be an alpha-amylase of bacterial or fungal origin, e.g. an alpha-amylase from B. licheniformis, described in GB 1,296,839.
  • alpha-amylases are DuramylTM, TermamylTM, StainzymeTM, Stainzyme PlusTM, Termamyl UltraTM, FungamylTM and BANTM (available from Novozymes A/S) and RapidaseTM, Maxamyl PTM, Purastar and Purastar OxAm (available from Gist-Brocades and Danisco Genencor).
  • the cellulase may be of bacterial or fungal origin. It may be a fungal cellulase from Humicola insolens (U.S. Pat. No. 4,435,307) or from Trichoderma, e.g. T. reesei or T. viride. Examples of cellulases are described in EP 0 495 257. Commercially available cellulases include CarezymeTM, CelluzymeTM, EndolaseTM, CellucleanTM (available from Novozymes), Puradax, Puradax HA, and Puradax EG (available from Danisco Genencor).
  • the oxidoreductase may be a peroxidase or an oxidase such as a laccase.
  • the peroxidase may be of plant, bacterial or fungal origin. Examples are peroxidases derived from a strain of Coprinus, e.g., C. cinerius or C. macrorhizus, or from a strain of Bacillus, e.g., B. pumilus, particularly peroxidase according to WO 91/05858. Suitable laccases herein include those of bacterial or fungal origin. Examples are laccases from Trametes, e.g., T. villosa or T. versicolor, or from a strain of Coprinus, e.g., C. cinereus, or from a strain of Myceliophthora, e.g., M. thermophila.
  • the lipolytic enzyme may be a lipase or cutinase of bacterial or fungal origin.
  • examples include a lipase from Thermomyces lanuginosus ( Humicola lanuginosa ) described in EP 258 068 and EP 305 216, a Rhizomucor miehei lipase, e.g., as described in EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C.
  • antarctica lipase A or B described in EP 214 761 a Fusarium oxysporum lipase (WO 98/26057), a Pseudomonas lipase such as a P. pseudoalcaligenes and P. alcaligenes lipase, e.g., as described in EP 218 272, a P. cepacia lipase, e.g., as described in EP 331 376, a P. stutzeri lipase, e.g., as disclosed in BP 1,372,034, a P. fluorescens lipase, a Bacillus lipase, e.g., a B.
  • subtilis lipase (Dartois et al., (1993), Biochemica et Biophysica acta 1131, 253-260), a B. stearothermophilus lipase (JP 64/744992), B. pumilus lipase (WO 91/16422), Penicillium camenbertii lipase (Yamaguchi et al., (1991), Gene 103, 61-67), the Geotrichum candidum lipase (Shimada, Y. et al., (1989), J. Biochem.
  • Rhizopus lipases such as a R. delemar lipase (Hass, M. J et al., (1991), Gene 109, 117-113), a R. niveus lipase (Kugimiya et al., (1992), Biosci. Biotech. Biochem. 56, 716-719) and a R. oryzae lipase. Additional examples are cutinase from Pseudomonas mendocina (WO 88/09367), cutinase from Fusarium solani pisi (WO 90/09446) and cutinase from Humicola insolens (WO 2001/092502).
  • the lipolytic enzyme may be a lipase variant, e.g. described in WO 2000/060063.
  • lipases examples include LipexTM, LipoprimeTM, LipopanTM, Lipopan FTM, Lipopan XtraTM, LipolaseTM, LipolaseTM Ultra, LipozymeTM, PalataseTM, ResinaseTM, NovozymTM 435 and LecitaseTM (all available from Novozymes A/S).
  • Other commercially available lipases include LumafastTM ( Pseudomonas mendocina lipase from Danisco Genencor); LipomaxTM ( Ps. pseudoalcaligenes lipase from Gist-Brocades or Danisco Genencor) and Bacillus sp. lipase from Solvay enzymes. Further lipases are available from other suppliers such as Lipase P “Amano” (Amano Pharmaceutical Co. Ltd.).
  • mannanases examples include MannawayTM (product of Novozymes) and MannaStar (product of Danisco Genencor).
  • the degree of identity between two amino acid sequences is calculated as the number of exact matches in an alignment of the two sequences, divided by the length of the shorter of the two sequences. The result is expressed in percent identity.
  • An exact match occurs when the two sequences have identical amino acid residues in the same positions of the overlap.
  • the length of a sequence is the number of amino acid residues in the sequence.
  • the alignment of the two amino acid sequences may be determined by using the
  • Needle program from the EMBOSS package (http://emboss.org) version 2.8.0.
  • the Needle program implements the global alignment algorithm described in Needleman, S. B. and Wunsch, C. D. (1970) J. Mol. Biol. 48, 443-453.
  • the substitution matrix used is BLOSUM62, gap opening penalty is 10, and gap extension penalty is 0.5.
  • the detergent composition is a liquid composition.
  • the composition may further comprise a second enzyme, particularly a lipase, an amylase, a cellulase or a carbohydrase.
  • the invention is particularly applicable to the formulation of liquid detergents where enzyme stability problems are pronounced.
  • the liquid detergent may be aqueous, typically containing 5-95% water, e.g. 5-15% or 20-70% water and 0-20% organic solvent (hereinafter, percentages by weight).
  • the detergent comprises a surfactant which may be anionic, non-ionic, cationic, amphoteric or a mixture of these types.
  • the detergent will usually contain 5-30% anionic surfactant such as linear alkyl benzene sulphonate (LAS), alpha-olefin sulphonate (AOS), alcohol ethoxy sulphate (AES) or soap. It may also contain 3-20% anionic surfactant such as nonyl phenol ethoxylate or alcohol ethoxylate.
  • the pH (measured in aqueous detergent solution) will usually be neutral or alkaline, e.g. 7-10.
  • the detergent may contain 1-40% of a detergent builder such as zeolite, phosphate, phosphonate, citrate, NTA, EDTA or DTPA, or it may be unbuilt (i.e. essentially free of a detergent builder). It may also contain other conventional detergent ingredients, e.g. fabric conditioners, foam boosters, bactericides, optical brighteners and perfumes.
  • the detergent composition may be a fabric cleaning compositions, hard surface cleansing compositions, light duty cleaning compositions including dish cleansing compositions and automatic dishwasher detergent compositions.
  • the liquid detergent composition may comprise from about 0.0001% to about 10%, more particularly from about 0.00015% to about 1%, and most particularly from about 0.001% to about 0.1% of the inhibitor
  • a stabilized liquid enzyme formulation typically contains 0.5-20% by weight, particularily 1-10% by weight, of enzyme protein (total of protease and optional second enzyme) and 0.01%-10% of the inhibitor, more particularly 0.05-5% by weight and most particularly 0.1%-2% by weight of the inhibitor.
  • a liquid detergent formulation will typically contain 0.04-400 micromolar enzyme (or 1-10000 mg EP/L), more particularily 0.16-160 micromolar enzyme (4-4400 mg EP/L) and most particularly 0.8-80 (20-2200 mg EP/L) and about 1-20 times more of the inhibitor, most particularly about 1-10 times more of the inhibitor.
  • the liquid detergent composition may contain water and other solvents as carriers.
  • Low molecular weight primary or secondary alcohols exemplified by methanol, ethanol, propanol, and iso-propanol are suitable.
  • Monohydric alcohols are preferred for solubilizing surfactants, but polyols such as those containing from about 2 to about 6 carbon atoms and from about 2 to about 6 hydroxy groups (e.g., 1,3-propanediol, ethylene glycol, glycerine, and 1,2-propanediol) can also be used.
  • the compositions may contain from about 5% to about 90%, typically from about 10% to about 50% of such carriers.
  • the detergent compositions herein will preferably be formulated such that during use in aqueous cleaning operations, the wash water will have a pH between about 6.8 and about 11. Finished products are typically formulated at this range.
  • Techniques for controlling pH at recommended usage levels include the use of, for example, buffers, alkalis, and acids. Such techniques are well known to those skilled in the art.
  • the formulator may wish to employ various builders at levels from about 5% to about 50% by weight.
  • Typical builders include the 1-10 micron zeolites, polycarboxylates such as citrate and oxydisuccinates, layered silicates, phosphates, and the like.
  • Other conventional builders are listed in standard formularies.
  • peptide aldehydes of the invention were produced by a custom peptide synthesis company, all with a purity >80%.
  • the peptide aldehydes were dissolved in DMSO to a concentration of 10 mg/ml before use.
  • a model liquid detergent A was prepared for testing the various stabilizers:
  • detergents were prepared by adding stabilizers to detergent A:
  • Stabilizer Molar ratio of (from a 10 mg/ml inhibitor relative Detergent ID Detergent A solution) to protease B 100 g 1.5 mg F-CO-RVF-H 3 C 100 g 2.5 mg F-CO-RVF-H 5 D 100 g 5.0 mg F-CO-RVF-H 10 E 100 g 1.5 mg F-CO-RVY-H 3 F 100 g 2.6 mg F-CO-RVY-H 5 G 100 g 5.1 mg F-CO-RVY-H 10 H 100 g 1.2 mg F-CO-GGY-H 3 J 100 g 2.0 mg F-CO-GGY-H 5 K 100 g 3.9 mg F-CO-GGY-H 10
  • the detergents were placed in closed glasses at 35° C. and 40° C. Residual activity of lipase and protease was measured (by comparison to a reference stored at ⁇ 18° C.) at different times, using standard enzyme analytical methods available at Novozymes (protease measured by hydrolysis of N,N—dimethylcasein at 40° C., pH 8.3 and lipase measured by hydrolysis of p-nitrophenyl valerate at 40° C., pH 7.7).
  • peptide aldehydes of the invention are very efficient as protease stabilizers and as stabilizers for a second enzyme in the presence of a protease.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Peptide aldehydes containing a ureido group are effective as stabilizers for protease in a detergent composition, and as stabilizers for a second enzyme in a liquid composition with a protease.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a liquid detergent composition comprising a surfactant and a protease and to a liquid enzyme composition comprising a protease and optionally a second enzyme. More particularly, it relates to such compositions incorporating a compound which stabilizes the protease and/or the second enzyme. Further, the invention also relates to a stabilizing compound for use in such compositions.
    • BACKGROUND OF THE INVENTION
  • EP 0 583 534 A, WO 94/04651 A, WO 98/13458 A and WO 2007/145963 A describe enzyme stabilization in liquid detergent compositions comprising a reversible peptide aldehyde protease inhibitor. WO 95/25791 A describes methods for manufacturing protease enzymes using non-protein protease inhibitors.
  • α-MAPI, antipain, GE20372A and chymostatin A, B and C are described as peptide aldehydes with activity as protease inhibitors: R. J. Broadbridge et al., Chem. Commun. (1998), 1449. E. Sarubbi et al., FEBS Letters, 319 (3), 253-256 (1993). I. J. Galpin et al., Int. J. Peptide Protein Res., 23, 1984, 477-486.
    • SUMMARY OF THE INVENTION
  • The inventors have found that certain peptide aldehydes containing a “double N-capping group” (such as ureido (N—CO—N), oxamide (N—CO—CO—N), thioureido (N—CS—N), dithio-oxamide (N—CS—CS—N) or thiooxamide (N—CS—CO—N) group) are effective as stabilizers for proteases in liquid enzyme formulations and in liquid detergent compositions, and as stabilizers for a second enzyme in a liquid composition with a protease. They also found that the peptide aldehydes can be released from the protease when the enzyme formulation or detergent composition is diluted with water. Accordingly, the invention provides a detergent composition comprising a surfactant, a protease and a stabilizer of the formula:

  • P—O-(Ai-X)n-An+1-H
  • wherein one X is the “double N-capping group” CO, CO—CO, CS, CS—CS or CS—CO (most preferably CO), and the other X'es are nothing (i.e., a chemical bond),
  • wherein n=1-10, preferably 2-5, most preferably 3
  • wherein i is an integer from 1 to n
  • wherein each Ai and An+1 is an amino acid residue having the structure:
      • —NH—CR—CO—for a residue to the right of the double N-capping group, or
      • —CO—CR—NH— for a residue to the left of the double N-capping group
  • wherein R is H— or an optionally substituted alkyl or alkylaryl group which may optionally include a hetero atom and may optionally be linked to the N atom, and
  • wherein P is hydrogen or any C-terminal protection group.
  • The invention also provides an enzyme composition, comprising a protease at a concentration of at least 0.1% by weight of enzyme protein and a stabilizer of the above formula.
  • Furthermore, the invention provides an enzyme composition, comprising a protease, a second enzyme and a stabilizer of the above formula.
  • Finally, the invention provides a stabilizer having the formula HO-A1-CO-A2-A3-A4-H, wherein A1 is a Phe residue, A2 is an Arg or Gly residue, A3 is a Val or Gly residue, and A4 is a Tyr residue.
    • DETAILED DESCRIPTION OF THE INVENTION Stabilizer
  • The peptide aldehyde used as a protease stabilizer has the structure P—O-(AiX)n-An+1-H with a “double N-capping group” X=CO, CO—CO, CS, CS—CS or CS—CO. It preferably contains four amino acid residues and preferably a ureido group (—NH—CO—NH—) between two of the residues. Thus, the structure is P—O-A1-CO-A2-A3-A4-H, P—O-A1-A2-CO-A3-A4-H or P—O-A1-A2-A3-CO-A4-H, where the amino acid residue(s) to the right of the ureido group has/have the structure —NH—CR—CO—, and the residue(s) to the left of the ureido group is/are inverted to —CO—CR—NH—.
  • Ai and An+1, most preferably A1 and/or A2 and/or A3 and/or A4 may be a residue of an amino acid, e.g. an L-amino acid, particularly a naturally occurring amino acid, L-norleucine (Nle), L-norvaline (Nva) or capreomycidine (Cpd). In particular, A1 may be Tyr, Leu, Phe, Met, Nle or Nva; A2 may be Gly, Ala, Val, Arg, Leu or Cpd; A3 may be Ala, Val, Gly, Leu, or Ile; and A4 may be Phe, Tyr, Leu, Nva, Nle, Met or Arg.
  • P may be H— or the C-terminal protection group Me-, Et- or CF3—
  • The stabilizer may have the formula HO-A1-CO-A2-A3-A4-H, e.g. the following compounds (where each amino acid is in the L-form unless indicated):
  • Short name A1 A2 A3 A4
    α-MAPI Phe Arg Val Phe
    β-MAPI Phe Arg Val D-Phe
    F-CO-RVY-H Phe Arg Val Tyr
    F-CO-GGY-H Phe Gly Gly Tyr
    F-CO-GAF-H Phe Gly Ala Phe
    F-CO-GAY-H Phe Gly Ala Tyr
    F-CO-GAL-H Phe Gly Ala Leu
    F-CO-GA-Nva-H Phe Gly Ala Nva
    F-CO-GA-Nle-H Phe Gly Ala Nle
    Y-CO-RVY-H Tyr Arg Val Tyr
    Y-CO-GAY-H Tyr Gly Ala Tyr
    F-CS-RVF-H Phe Arg Val Phe
    F-CS-RVY-H Phe Arg Val Tyr
    F-CS-GAY-H Phe Gly Ala Tyr
    Antipain Phe Arg Val Arg
    GE20372A Tyr Arg Val Phe
    GE20372B Tyr Arg Val D-Phe
    Chymostatin A Phe Cpd Leu Phe
    Chymostatin B Phe Cpd Val Phe
    Chymostatin C Phe Cpd Ile Phe
  • The stabilizer may be prepared by methods known in the art, e.g. as described by R. J. Broadbridge et al., Chem. Commun., 1998, 1449-1450; by P. Page et al., J. Org. Chem., 1999, 64, 794-799; or by I. J. Galpin et al., Int. J. Peptide Protein Res., 23, 1984, 477-486.
  • The molar ratio of the inhibitor to the protease may be 0.1:1 to 100:1, e.g. 0.5:1-50:1, 1:1-25:1 or 2:1-10:1.
    • Optional Second Stabilizer
  • Optionally, the enzyme or detergent composition may comprise one or more other protease stabilizers. Examples are boronic acid derivatives, organic acids, protein and peptide type inhibitors and peptide aldehydes, e.g. as described in WO 1995/029223, WO 1996/041859, WO 2006/045310, WO 2006/045310, WO 2007/113142, WO 2008/116915, WO 2009/095425 (patent application EP 08150977.0), WO 2009/118375 (patent application EP 08153299.6), WO 2007/145963, or WO 2007/141736.
    • Protease
  • The protease may be a serine, cysteine or aspartic protease. It may be an alkaline microbial protease, a trypsin-like protease or a subtilisin, e.g. a subtilisin derived from Bacillus. The protease may be subtilisin Novo, subtilisin Carlsberg, subtilisin BPN′, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279), trypsin (e.g. of porcine or bovine origin), the Fusarium protease described in WO 89/06270, a protease described in WO 1998/020115, WO 01/44452, WO 01/58275, WO 01/58276, WO 2003/006602, or WO 2004/099401, or it may have an amino acid sequence which is at least 90%, at least 95%, at least 98% or at least 99% identical to one of these.
  • Examples of commercially available proteases (peptidases) include Kannase™, Everlase™, Esperase™, Alcalase™, Neutrase™, Durazym™, Savinase™, Ovozyme™, Liquanase™, Polarzyme™, Pyrase™, Pancreatic Trypsin NOVO (PTN), Bio-Feed™ Pro and Clear-Lens™Pro (all available from Novozymes A/S, Bagsvaerd, Denmark). Other commercially available proteases include Ronozyme™ Pro, Maxatase™, Maxacal™, Maxapem™, Opticlean™, Properase™, Purafect™, Purafect Ox™ and Purafact Prime™ (available from Danisco Genencor, Gist-Brocades, BASF, or DSM Nutritional Products).
    • Second Enzyme
  • In addition to the protease, the liquid composition may optionally comprise one or more other enzymes, e.g. selected among amylases, lipolytic enzymes (particularly lipases), cellulases, mannanases and oxidoreductases.
  • The amylase may be an alpha-amylase of bacterial or fungal origin, e.g. an alpha-amylase from B. licheniformis, described in GB 1,296,839. Commercially available amylases are Duramyl™, Termamyl™, Stainzyme™, Stainzyme Plus™, Termamyl Ultra™, Fungamyl™ and BAN™ (available from Novozymes A/S) and Rapidase™, Maxamyl P™, Purastar and Purastar OxAm (available from Gist-Brocades and Danisco Genencor).
  • The cellulase may be of bacterial or fungal origin. It may be a fungal cellulase from Humicola insolens (U.S. Pat. No. 4,435,307) or from Trichoderma, e.g. T. reesei or T. viride. Examples of cellulases are described in EP 0 495 257. Commercially available cellulases include Carezyme™, Celluzyme™, Endolase™, Celluclean™ (available from Novozymes), Puradax, Puradax HA, and Puradax EG (available from Danisco Genencor).
  • The oxidoreductase may be a peroxidase or an oxidase such as a laccase. The peroxidase may be of plant, bacterial or fungal origin. Examples are peroxidases derived from a strain of Coprinus, e.g., C. cinerius or C. macrorhizus, or from a strain of Bacillus, e.g., B. pumilus, particularly peroxidase according to WO 91/05858. Suitable laccases herein include those of bacterial or fungal origin. Examples are laccases from Trametes, e.g., T. villosa or T. versicolor, or from a strain of Coprinus, e.g., C. cinereus, or from a strain of Myceliophthora, e.g., M. thermophila.
  • The lipolytic enzyme may be a lipase or cutinase of bacterial or fungal origin. Examples include a lipase from Thermomyces lanuginosus (Humicola lanuginosa) described in EP 258 068 and EP 305 216, a Rhizomucor miehei lipase, e.g., as described in EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C. antarctica lipase A or B described in EP 214 761, a Fusarium oxysporum lipase (WO 98/26057), a Pseudomonas lipase such as a P. pseudoalcaligenes and P. alcaligenes lipase, e.g., as described in EP 218 272, a P. cepacia lipase, e.g., as described in EP 331 376, a P. stutzeri lipase, e.g., as disclosed in BP 1,372,034, a P. fluorescens lipase, a Bacillus lipase, e.g., a B. subtilis lipase (Dartois et al., (1993), Biochemica et Biophysica acta 1131, 253-260), a B. stearothermophilus lipase (JP 64/744992), B. pumilus lipase (WO 91/16422), Penicillium camenbertii lipase (Yamaguchi et al., (1991), Gene 103, 61-67), the Geotrichum candidum lipase (Shimada, Y. et al., (1989), J. Biochem.
  • 106, 383-388), and various Rhizopus lipases such as a R. delemar lipase (Hass, M. J et al., (1991), Gene 109, 117-113), a R. niveus lipase (Kugimiya et al., (1992), Biosci. Biotech. Biochem. 56, 716-719) and a R. oryzae lipase. Additional examples are cutinase from Pseudomonas mendocina (WO 88/09367), cutinase from Fusarium solani pisi (WO 90/09446) and cutinase from Humicola insolens (WO 2001/092502). The lipolytic enzyme may be a lipase variant, e.g. described in WO 2000/060063.
  • Examples of commercially available lipases include Lipex™, Lipoprime™, Lipopan™, Lipopan F™, Lipopan Xtra™, Lipolase™, Lipolase™ Ultra, Lipozyme™, Palatase™, Resinase™, Novozym™ 435 and Lecitase™ (all available from Novozymes A/S). Other commercially available lipases include Lumafast™ (Pseudomonas mendocina lipase from Danisco Genencor); Lipomax™ (Ps. pseudoalcaligenes lipase from Gist-Brocades or Danisco Genencor) and Bacillus sp. lipase from Solvay enzymes. Further lipases are available from other suppliers such as Lipase P “Amano” (Amano Pharmaceutical Co. Ltd.).
  • Examples of mannanases include Mannaway™ (product of Novozymes) and MannaStar (product of Danisco Genencor).
    • Sequence Identity
  • The degree of identity between two amino acid sequences is calculated as the number of exact matches in an alignment of the two sequences, divided by the length of the shorter of the two sequences. The result is expressed in percent identity. An exact match occurs when the two sequences have identical amino acid residues in the same positions of the overlap. The length of a sequence is the number of amino acid residues in the sequence. The alignment of the two amino acid sequences may be determined by using the
  • Needle program from the EMBOSS package (http://emboss.org) version 2.8.0. The Needle program implements the global alignment algorithm described in Needleman, S. B. and Wunsch, C. D. (1970) J. Mol. Biol. 48, 443-453. The substitution matrix used is BLOSUM62, gap opening penalty is 10, and gap extension penalty is 0.5.
  • Alternatively, the alignment may be done by using the MegAlign program (version 7) developed by DNASTAR Inc., part of the Lasergene suite, based on Hein, J. J. (1990). “Unified approach to alignment and phylogenies.” In Methods in Enzymology, Vol. 183: pp. 626-645. Using the Jotun Hein Method and the settings GAP PENALTY=11, GAP LENGTH PENALTY=3 for multiple alignments and KTUPLE=2 for pairwise alignments a series of percentage identity values can be calculated.
    • Detergent Composition
  • The detergent composition is a liquid composition. In addition to the protease, the composition may further comprise a second enzyme, particularly a lipase, an amylase, a cellulase or a carbohydrase.
  • The invention is particularly applicable to the formulation of liquid detergents where enzyme stability problems are pronounced. The liquid detergent may be aqueous, typically containing 5-95% water, e.g. 5-15% or 20-70% water and 0-20% organic solvent (hereinafter, percentages by weight).
  • The detergent comprises a surfactant which may be anionic, non-ionic, cationic, amphoteric or a mixture of these types. The detergent will usually contain 5-30% anionic surfactant such as linear alkyl benzene sulphonate (LAS), alpha-olefin sulphonate (AOS), alcohol ethoxy sulphate (AES) or soap. It may also contain 3-20% anionic surfactant such as nonyl phenol ethoxylate or alcohol ethoxylate.
  • The pH (measured in aqueous detergent solution) will usually be neutral or alkaline, e.g. 7-10. The detergent may contain 1-40% of a detergent builder such as zeolite, phosphate, phosphonate, citrate, NTA, EDTA or DTPA, or it may be unbuilt (i.e. essentially free of a detergent builder). It may also contain other conventional detergent ingredients, e.g. fabric conditioners, foam boosters, bactericides, optical brighteners and perfumes.
  • The detergent composition may be a fabric cleaning compositions, hard surface cleansing compositions, light duty cleaning compositions including dish cleansing compositions and automatic dishwasher detergent compositions.
  • The liquid detergent composition may comprise from about 0.0001% to about 10%, more particularly from about 0.00015% to about 1%, and most particularly from about 0.001% to about 0.1% of the inhibitor
  • Thus, a stabilized liquid enzyme formulation typically contains 0.5-20% by weight, particularily 1-10% by weight, of enzyme protein (total of protease and optional second enzyme) and 0.01%-10% of the inhibitor, more particularly 0.05-5% by weight and most particularly 0.1%-2% by weight of the inhibitor.
  • A liquid detergent formulation will typically contain 0.04-400 micromolar enzyme (or 1-10000 mg EP/L), more particularily 0.16-160 micromolar enzyme (4-4400 mg EP/L) and most particularly 0.8-80 (20-2200 mg EP/L) and about 1-20 times more of the inhibitor, most particularly about 1-10 times more of the inhibitor.
  • The liquid detergent composition may contain water and other solvents as carriers. Low molecular weight primary or secondary alcohols exemplified by methanol, ethanol, propanol, and iso-propanol are suitable. Monohydric alcohols are preferred for solubilizing surfactants, but polyols such as those containing from about 2 to about 6 carbon atoms and from about 2 to about 6 hydroxy groups (e.g., 1,3-propanediol, ethylene glycol, glycerine, and 1,2-propanediol) can also be used. The compositions may contain from about 5% to about 90%, typically from about 10% to about 50% of such carriers.
  • The detergent compositions herein will preferably be formulated such that during use in aqueous cleaning operations, the wash water will have a pH between about 6.8 and about 11. Finished products are typically formulated at this range. Techniques for controlling pH at recommended usage levels include the use of, for example, buffers, alkalis, and acids. Such techniques are well known to those skilled in the art.
  • When formulating the hard surface cleaning compositions and fabric cleaning compositions of the present invention, the formulator may wish to employ various builders at levels from about 5% to about 50% by weight. Typical builders include the 1-10 micron zeolites, polycarboxylates such as citrate and oxydisuccinates, layered silicates, phosphates, and the like. Other conventional builders are listed in standard formularies.
    • EXAMPLES Example 1
  • Various peptide aldehydes of the invention were produced by a custom peptide synthesis company, all with a purity >80%. The peptide aldehydes were dissolved in DMSO to a concentration of 10 mg/ml before use.
  • A model liquid detergent A was prepared for testing the various stabilizers:
  • Component % w/w
    Sodium alkylethoxy sulphate (C9-15, 2EO) 6.0
    Sodium dodecyl benzene sulphonate 3.0
    Sodium toluene sulphonate 3.0
    Oleic acid 2.0
    Primary alcohol ethoxylate (C12-15, 7EO) 3.0
    Primary alcohol ethoxylate (C12-15, 3EO) 2.5
    Ethanol 0.5
    Monopropylene glycol 2.0
    Tri-sodium citrate 2H2O 4.0
    Triethanolamine 0.4
    Protease (Savinase 16 LEX) 0.5
    Lipase (Lipex 100L) 0.5
    De-ionized water Ad 100%
    pH adjusted to 8.5 with NaOH
  • Further, the following detergents were prepared by adding stabilizers to detergent A:
  • Stabilizer Molar ratio of
    (from a 10 mg/ml inhibitor relative
    Detergent ID Detergent A solution) to protease
    B 100 g 1.5 mg F-CO-RVF-H 3
    C 100 g 2.5 mg F-CO-RVF-H 5
    D 100 g 5.0 mg F-CO-RVF-H 10
    E 100 g 1.5 mg F-CO-RVY-H 3
    F 100 g 2.6 mg F-CO-RVY-H 5
    G 100 g 5.1 mg F-CO-RVY-H 10
    H 100 g 1.2 mg F-CO-GGY-H 3
    J 100 g 2.0 mg F-CO-GGY-H 5
    K 100 g 3.9 mg F-CO-GGY-H 10
  • The detergents were placed in closed glasses at 35° C. and 40° C. Residual activity of lipase and protease was measured (by comparison to a reference stored at −18° C.) at different times, using standard enzyme analytical methods available at Novozymes (protease measured by hydrolysis of N,N—dimethylcasein at 40° C., pH 8.3 and lipase measured by hydrolysis of p-nitrophenyl valerate at 40° C., pH 7.7).
  • % residual activity
    Residual protease Residual lipase
    activity activity
    4 weeks 1 week 1 week
    Detergent 35° C. 40° C. 35° C.
    A (reference) 20 11 3
    B (F-CO-RVF-H, 3x) 63 22
    C (F-CO-RVF-H, 5x) 83 51
    D (F-CO-RVF-H, 10x) 78 69
    E (F-CO-RVY-H, 3x) 62 55 17
    F (F-CO-RVY-H, 5x) 81 75 53
    G (F-CO-RVY-H, 10x) 86 81 69
    H (F-CO-GGY-H, 3x) 26 17 3
    J (F-CO-GGY-H, 5x) 31 20 4
    K (F-CO-GGY-H, 10x) 38 28 5
  • From this example it is clear that the peptide aldehydes of the invention are very efficient as protease stabilizers and as stabilizers for a second enzyme in the presence of a protease.

Claims (13)

1-14. (canceled)
15. A liquid detergent composition comprising a surfactant, a protease and a peptide aldehyde of the formula P—O-A1-CO-A2-A3-A4-H wherein
P is H, Me, Et or CF3;
Al is a residue of Tyr, Leu, Phe, Met, Nle or Nva;
A2 is a residue of Gly, Ala, Val, Arg, Leu or Cpd;
A3 is a residue of Val, Gly, Leu or Ile;
A4 is a residue of Phe, Tyr, Leu, Nva, Nle, Met or Arg, wherein CO is a double N-capping group.
16. The composition of claim 15, wherein the peptide aldehyde has the formula Phe-CO-Arg-Val-Phe-H, Phe-CO-Arg-Val-Tyr-H or Phe-CO-Gly-Gly-Tyr-H.
17. The composition of claim 15, which further comprises a second enzyme selected from the group consisting of lipase, amylase, cellulase, and carbohydrase.
18. The composition of claim 15, wherein the protease is an alkaline protease, an aspartic protease, a serine protease, a cysteine protease, or a subtilisin.
19. A liquid enzyme detergent composition, comprising a protease at a concentration of at least 0.1% by weight of enzyme protein and a compound of the formula P—O-A1-CO-A2-A3-A4-H wherein
P is H, Me, Et or CF3;
Al is a residue of Tyr, Leu, Phe, Met, Nle or Nva;
A2 is a residue of Gly, Ala, Val, Arg, Leu or Cpd;
A3 is a residue of Val, Gly, Leu or Ile;
A4 is a residue of Phe, Tyr, Leu, Nva, Nle, Met or Arg, wherein CO is a double N-capping group.
20. A liquid enzyme detergent composition, comprising a protease, a second enzyme and a compound of the formula P—O-A1-CO-A2-A3-A4-H wherein
P is H, Me, Et or CF3;
Al is a residue of Tyr, Leu, Phe, Met, Nle or Nva;
A2 is a residue of Gly, Ala, Val, Arg, Leu or Cpd;
A3 is a residue of Val, Gly, Leu or Ile;
A4 is a residue of Phe, Tyr, Leu, Nva, Nle, Met or Arg, wherein CO is a double N-capping group.
21. The composition of claim 15, wherein molar ratio of peptide aldehyde to protease is 0.1:1.
22. The composition of claim 15, wherein molar ratio of peptide aldehyde to protease is 100:1.
23. The composition of claim 15, wherein molar ratio of peptide aldehyde to protease is 0.5:1 to 50:1.
24. The composition of claim 15, wherein the composition is a laundry detergent composition.
25. The composition of claim 19, wherein the composition is a laundry detergent composition.
26. The composition of claim 20, wherein the composition is a laundry detergent composition.
US16/749,716 2008-11-13 2020-01-22 Detergent Composition Abandoned US20200157472A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/749,716 US20200157472A1 (en) 2008-11-13 2020-01-22 Detergent Composition

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP08169063.8 2008-11-13
EP08169063 2008-11-13
US11798908P 2008-11-26 2008-11-26
PCT/EP2009/064972 WO2010055052A1 (en) 2008-11-13 2009-11-11 Detergent composition
US201113124089A 2011-04-13 2011-04-13
US16/749,716 US20200157472A1 (en) 2008-11-13 2020-01-22 Detergent Composition

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US13/124,089 Continuation US10577568B2 (en) 2008-11-13 2009-11-11 Detergent composition
PCT/EP2009/064972 Continuation WO2010055052A1 (en) 2008-11-13 2009-11-11 Detergent composition

Publications (1)

Publication Number Publication Date
US20200157472A1 true US20200157472A1 (en) 2020-05-21

Family

ID=40521614

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/124,089 Active US10577568B2 (en) 2008-11-13 2009-11-11 Detergent composition
US16/749,716 Abandoned US20200157472A1 (en) 2008-11-13 2020-01-22 Detergent Composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/124,089 Active US10577568B2 (en) 2008-11-13 2009-11-11 Detergent composition

Country Status (4)

Country Link
US (2) US10577568B2 (en)
EP (1) EP2358857B1 (en)
CN (2) CN102209776B (en)
WO (1) WO2010055052A1 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0909084B1 (en) 2008-03-26 2020-11-03 Novozymes A/S aldehyde peptide and liquid composition
WO2011036153A1 (en) * 2009-09-25 2011-03-31 Novozymes A/S Detergent composition
JP6334396B2 (en) 2011-07-01 2018-05-30 ノボザイムス アクティーゼルスカブ Stabilized subtilisin composition
JP6306504B2 (en) 2011-07-01 2018-04-04 ノボザイムス アクティーゼルスカブ Liquid detergent composition
WO2013026796A1 (en) 2011-08-19 2013-02-28 Novozymes A/S Polypeptides having protease activity
CA2897163A1 (en) * 2013-03-08 2014-09-12 Manus Bernard Monroe Citrate salts for eliminating odors
EP2970830B1 (en) 2013-03-14 2017-12-13 Novozymes A/S Enzyme and inhibitor contained in water-soluble films
EP2989117B1 (en) 2013-04-23 2019-06-12 Novozymes A/S Liquid automatic dish washing detergent compositions with stabilised subtilisin
JP7020778B2 (en) 2013-05-03 2022-02-16 ノボザイムス アクティーゼルスカブ Detergent enzyme microencapsulation
CN106471110A (en) * 2014-07-03 2017-03-01 诺维信公司 Improved non-protein enzyme enzyme stabilization
CN117904083A (en) 2014-12-19 2024-04-19 诺维信公司 Protease variants and polynucleotides encoding the same
US10570352B2 (en) 2015-01-08 2020-02-25 Stepan Company Cold-water laundry detergents
WO2016160407A1 (en) 2015-03-31 2016-10-06 Stepan Company Detergents based on alpha-sulfonated fatty ester surfactants
WO2017001673A1 (en) 2015-07-01 2017-01-05 Novozymes A/S Methods of reducing odor
CN107969136B (en) 2015-07-06 2021-12-21 诺维信公司 Lipase variants and polynucleotides encoding same
WO2017036917A1 (en) * 2015-08-28 2017-03-09 Unilever N.V. Liquid detergency composition comprising lipase and protease
US10934535B2 (en) 2015-10-07 2021-03-02 Novozymes A/S Detergent composition comprising a DNase
US10675589B2 (en) 2015-10-14 2020-06-09 Novozymes A/S Cleaning of water filtration membranes
WO2017129331A1 (en) * 2016-01-28 2017-08-03 Novozymes A/S Method for cleaning a medical or dental instrument
EP3464538A1 (en) 2016-05-31 2019-04-10 Novozymes A/S Stabilized liquid peroxide compositions
US20200140786A1 (en) 2016-09-29 2020-05-07 Novozymes A/S Use of enzyme for washing, method for washing and warewashing composition
CN110312795B (en) 2016-12-21 2024-07-23 丹尼斯科美国公司 Protease variants and uses thereof
EP4424805A3 (en) 2016-12-21 2024-11-20 Danisco Us Inc Bacillus gibsonii-clade serine proteases
CN110651038B (en) 2017-05-05 2025-02-18 诺维信公司 Composition comprising lipase and sulfite
CN111108183A (en) 2017-06-30 2020-05-05 诺维信公司 Enzyme Serum Composition
CN111527190A (en) 2017-11-01 2020-08-11 诺维信公司 Polypeptides and compositions comprising such polypeptides
US20200291330A1 (en) 2017-11-01 2020-09-17 Novozymes A/S Polypeptides and Compositions Comprising Such Polypeptides
EP3717643A1 (en) 2017-11-29 2020-10-07 Danisco US Inc. Subtilisin variants having improved stability
US20210002588A1 (en) 2018-03-13 2021-01-07 Novozymes A/S Microencapsulation Using Amino Sugar Oligomers
WO2019201783A1 (en) 2018-04-19 2019-10-24 Novozymes A/S Stabilized cellulase variants
CN118530973A (en) 2018-04-19 2024-08-23 诺维信公司 Stabilized cellulase variants
WO2019245705A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
EP3810767A1 (en) 2018-06-19 2021-04-28 Danisco US Inc. Subtilisin variants
WO2020068486A1 (en) 2018-09-27 2020-04-02 Danisco Us Inc Compositions for medical instrument cleaning
EP3647397A1 (en) 2018-10-31 2020-05-06 Henkel AG & Co. KGaA Cleaning compositions containing dispersins iv
EP3647398B1 (en) 2018-10-31 2024-05-15 Henkel AG & Co. KGaA Cleaning compositions containing dispersins v
EP3887515A1 (en) 2018-11-28 2021-10-06 Danisco US Inc. Subtilisin variants having improved stability
BR112021020439A2 (en) 2019-04-12 2022-05-24 Novozymes As Stabilized variants of glycoside hydrolase
CN114174504A (en) 2019-05-24 2022-03-11 丹尼斯科美国公司 Subtilisin variants and methods of use
US20220403298A1 (en) 2019-07-12 2022-12-22 Novozymes A/S Enzymatic emulsions for detergents
CN114929848A (en) 2019-12-20 2022-08-19 诺维信公司 Stable liquid boron-free enzyme compositions
WO2021123307A2 (en) 2019-12-20 2021-06-24 Novozymes A/S Polypeptides having proteolytic activity and use thereof
EP4133066A1 (en) 2020-04-08 2023-02-15 Novozymes A/S Carbohydrate binding module variants
US20230313165A1 (en) 2020-08-25 2023-10-05 Novozymes A/S Variants of a family 44 xyloglucanase
EP4032966A1 (en) 2021-01-22 2022-07-27 Novozymes A/S Liquid enzyme composition with sulfite scavenger
WO2022189521A1 (en) 2021-03-12 2022-09-15 Novozymes A/S Polypeptide variants
CA3238839A1 (en) 2021-12-16 2023-06-22 The Procter & Gamble Company Home care composition
EP4448749A2 (en) 2021-12-16 2024-10-23 Danisco US Inc. Subtilisin variants and methods of use
EP4448751A2 (en) 2021-12-16 2024-10-23 Danisco US Inc. Subtilisin variants and methods of use
CA3240641A1 (en) 2021-12-16 2023-06-22 Michelle Jackson Automatic dishwashing composition comprising a protease
US20230365897A1 (en) 2021-12-16 2023-11-16 The Procter & Gamble Company Fabric and home care composition including a protease
EP4448706A1 (en) 2021-12-16 2024-10-23 The Procter & Gamble Company Home care composition comprising an amylase
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
CN119855892A (en) 2022-09-02 2025-04-18 丹尼斯科美国公司 Detergent compositions and methods relating thereto
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use
WO2024126697A1 (en) 2022-12-14 2024-06-20 Novozymes A/S High strength liquid protease formulations
WO2024131880A2 (en) 2022-12-23 2024-06-27 Novozymes A/S Detergent composition comprising catalase and amylase
WO2024163584A1 (en) 2023-02-01 2024-08-08 Danisco Us Inc. Subtilisin variants and methods of use
WO2024186819A1 (en) 2023-03-06 2024-09-12 Danisco Us Inc. Subtilisin variants and methods of use
WO2024183958A1 (en) 2023-03-09 2024-09-12 Norfalk Aps Use of mono-ester glycolipids in laundry detergents
WO2025085351A1 (en) 2023-10-20 2025-04-24 Danisco Us Inc. Subtilisin variants and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998795A (en) * 1975-06-23 1976-12-21 American Home Products Corporation (Acyl-D-α-amino acid-gly-gly-tyr-ala)1 -somatostatin
GB8321924D0 (en) * 1983-08-15 1983-09-14 Unilever Plc Enzymatic machine-dishwashing compositions
ATE149562T1 (en) * 1992-08-14 1997-03-15 Procter & Gamble LIQUID DETERGENTS CONTAINING PEPTIDEALDEHYDE
JPH09510363A (en) * 1994-03-22 1997-10-21 ザ、プロクター、エンド、ギャンブル、カンパニー Production of protease enzymes using non-protein protease inhibitors
ITPD940054A1 (en) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl SULPHATED POLYSACCHARIDES
US5861366A (en) * 1994-08-31 1999-01-19 Ecolab Inc. Proteolytic enzyme cleaner
CA2265879A1 (en) 1996-09-24 1998-04-02 Alan Carl Huber Liquid detergents containing proteolytic enzyme and protease inhibitors
US6165966A (en) * 1996-09-24 2000-12-26 The Procter & Gamble Company Liquid detergents containing proteolytic enzyme and protease inhibitors
US6331512B1 (en) * 1999-09-29 2001-12-18 Amway Corporation Phosphate-free automatic dishwashing detergent
CA2563533C (en) * 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
US20080009431A1 (en) * 2006-06-05 2008-01-10 Jean-Pol Boutique Enzyme stabilization
WO2011036153A1 (en) * 2009-09-25 2011-03-31 Novozymes A/S Detergent composition

Also Published As

Publication number Publication date
CN102209776A (en) 2011-10-05
US20110212877A1 (en) 2011-09-01
WO2010055052A1 (en) 2010-05-20
CN103589529A (en) 2014-02-19
US10577568B2 (en) 2020-03-03
CN102209776B (en) 2013-11-27
EP2358857A1 (en) 2011-08-24
EP2358857B1 (en) 2017-05-03

Similar Documents

Publication Publication Date Title
US10577568B2 (en) Detergent composition
EP2245060B1 (en) Liquid enzyme composition
US9181296B2 (en) Stabilized liquid enzyme compositions
EP2726590B1 (en) Liquid detergent composition
EP2004789B1 (en) A stabilized liquid enzyme composition
US8329632B2 (en) Detergent compositions and the use of enzyme combinations therein
EP3645692A1 (en) Enzyme slurry composition

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION